Skip to main content
. 2018 May 25;8:8169. doi: 10.1038/s41598-018-26449-7

Table 4.

Mean scores of BICAMS tests during and after MS relapse.

Test MSr group during relapse (MSr1) (N = 60) MSr group
1 month after relapse (MSr2) (N = 60)
MSr group
3 months after relapse (MSr3) (N = 60)
ANOVA Post hoc
SDMT 40.18 ± 11.42 46.20 ± 12.28 46.62 ± 10.96 F = 43.08;
p < 0.001*
MSr1 < MSr2,MSr3
MSr2 = MSr3
BVMT-R
(0–36)
22.57 ± 6.07 26.30 ± 4.56 26.93 ± 4.62 F = 34.73;
p < 0.001*
MSr1 < MSr2,MSr3
MSr2 = MSr3
CVLT-II
(0–80)
52.02 ± 9.61 58.45 ± 8.36 60.57 ± 9.59 F = 65.87;
p < 0.001
MSr1 < MSr2 < MSr3
CVLT-II delayed recall
(0–16)
12.23 ± 2.66 13.72 ± 2.22 13.98 ± 2.04 F = 33.84;
p < 0.001*
MSr1 < MSr2,MSr3
MSr2 = MSr3

MSr1 – relapsing MS patients during relapse, MSr2 – relapsing MS patients one month after relapse, MSr3 – relapsing MS patients three months after relapse, SDMT – Symbol Digit Modalities Test, BVMT-R – Brief Visuospatial Memory Test-Revised, CVLT-II – California verbal learning test, II ed.

*Repeated-measures analysis of variance (rmANOVA) with Greenhouse-Geisser correction for violation of sphericity was used.